MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202611107139 A) filed by Mrs. Shalini Vijay Rakhade; Lokhande Sudarshan Prakash; Chavan Atharav Pramod; Jare Gauri Ashru; Date Sakshi Ashok; Kadam Gauri Vishwanath; Dr. Hirasing Tarasing Manza; and Mrs. Suchita Krunal Nakade on September 06, 2026, for A Standardized Plant-Derived Multi-Bioactive Composition, Preparation System And Process For Pancreatic Cancer-Associated Applications.
Inventors include Mrs. Shalini Vijay Rakhade; Lokhande Sudarshan Prakash; Chavan Atharav Pramod; Jare Gauri Ashru; Date Sakshi Ashok; Kadam Gauri Vishwanath; Dr. Hirasing Tarasing Manza; and Mrs. Suchita Krunal Nakade.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: A standardized plant-derived multi-bioactive composition, preparation system and process are disclosed for pancreatic cancer-associated applications. The composition includes marker-standardized curcumin extract from Curcuma longa at 20-30% w/w, resveratrol extract from Vitis vinifera at 10-20% w/w, EGCG extract from Camellia sinensis at 10-15% w/w, berberine extract from Berberis aristata at 10-15% w/w, quercetin at 5-10% w/w, boswellic acid extract from Boswellia serrata at 5- 10% w/w, piperine from Piper nigrum, and pharmaceutically acceptable formulation components. A marker-gated preparation architecture verifies incoming extract potency, selects blend quantities within defined weight windows, optionally applies a bioavailability-enhancement operation, forms a dosage composition and performs a post-blend assay before batch release. The system supports oral, nanoparticulate, injectable or targeted-delivery embodiments while improving compositional reproducibility and traceability. Accompanied Drawing [FIGS. 1-2].
Disclaimer: Curated by HT Syndication.
